1. Home
  2. AGD vs CERS Comparison

AGD vs CERS Comparison

Compare AGD & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGD
  • CERS
  • Stock Information
  • Founded
  • AGD 2006
  • CERS 1991
  • Country
  • AGD United Kingdom
  • CERS United States
  • Employees
  • AGD N/A
  • CERS N/A
  • Industry
  • AGD Trusts Except Educational Religious and Charitable
  • CERS EDP Services
  • Sector
  • AGD Finance
  • CERS Technology
  • Exchange
  • AGD Nasdaq
  • CERS Nasdaq
  • Market Cap
  • AGD 263.6M
  • CERS 237.7M
  • IPO Year
  • AGD N/A
  • CERS 1997
  • Fundamental
  • Price
  • AGD $11.98
  • CERS $1.31
  • Analyst Decision
  • AGD
  • CERS Strong Buy
  • Analyst Count
  • AGD 0
  • CERS 2
  • Target Price
  • AGD N/A
  • CERS $3.50
  • AVG Volume (30 Days)
  • AGD 61.2K
  • CERS 1.2M
  • Earning Date
  • AGD 01-01-0001
  • CERS 08-05-2025
  • Dividend Yield
  • AGD 8.13%
  • CERS N/A
  • EPS Growth
  • AGD N/A
  • CERS N/A
  • EPS
  • AGD N/A
  • CERS N/A
  • Revenue
  • AGD N/A
  • CERS $192,510,000.00
  • Revenue This Year
  • AGD N/A
  • CERS $30.03
  • Revenue Next Year
  • AGD N/A
  • CERS $9.37
  • P/E Ratio
  • AGD N/A
  • CERS N/A
  • Revenue Growth
  • AGD N/A
  • CERS 13.25
  • 52 Week Low
  • AGD $8.20
  • CERS $1.12
  • 52 Week High
  • AGD $9.78
  • CERS $2.35
  • Technical
  • Relative Strength Index (RSI)
  • AGD 79.72
  • CERS 51.98
  • Support Level
  • AGD $11.56
  • CERS $1.27
  • Resistance Level
  • AGD $11.43
  • CERS $1.44
  • Average True Range (ATR)
  • AGD 0.12
  • CERS 0.07
  • MACD
  • AGD 0.03
  • CERS 0.01
  • Stochastic Oscillator
  • AGD 98.14
  • CERS 55.17

About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest

Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors among others.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: